# US 2022/0372528 A1 · Production of chemicals from renewable sources

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0372528 A1
- Document ID: US20220372528A1
- Status: Published application
- Kind: A1
- Application number: 17/605,389
- Filed: 2020-04-25
- Published: 2022-11-24
- Earliest claimed: 2019-04-25
- Assignees: Zymochem, Inc.
- Applicants: Zymochem, Inc.
- Inventors: Harshal Chokhawala; Jonathan Kuchenreuther; Jorge-Alonso Gutierrez; Yi-Shu Tai
- Web page: https://patentgrep.com/patent/US20220372528A1

## CPC

- C12N 9/0036: {acting on NADH or NADPH (1.6)}
- C12P 7/625: Polyesters of hydroxy carboxylic acids
- C12N 1/20: Bacteria; Culture media therefor
- C12N 9/88: Lyases (4.)
- C12N 15/52: Genes encoding for enzymes or proenzymes
- C12N 15/70: Vectors or expression systems specially adapted for E. coli
- C12P 7/04: acyclic
- C12P 7/18: polyhydric
- C12P 7/40: containing a carboxyl group {including Peroxycarboxylic acids}
- C12P 7/42: Hydroxy-carboxylic acids
- C12P 7/44: Polycarboxylic acids
- C12P 7/62: Carboxylic acid esters
- C12P 11/00: Preparation of sulfur-containing organic compounds
- C12Y 106/05005: NADPH:quinone reductase (1.6.5.5)
- C12Y 401/01004: Acetoacetate decarboxylase (4.1.1.4)
- C12Y 401/02045: Trans-o-hydroxybenzylidenepyruvate hydratase-aldolase (4.1.2.45)
- C12Y 402/0103: Glycerol dehydratase (4.2.1.30)
- C12Y 402/01034: (S)-2-Methylmalate dehydratase (4.2.1.34)
- C12N 2800/101: for bacteria
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Y: ENZYMES

## Abstract

Among other things, the present disclosure provides biosynthesis polypeptides, methods, and non-naturally occurring microbial organisms for preparing various compounds such as 1,5-pentanediol, adipic acid, 1,6-hexanediol, 6-hydroxy hexanoic acid, and 2-keto carboxylic acids.

## Claims

### Claim 1

A method comprising:
contacting pyruvate and an aliphatic aldehyde with an aldol-dehydration product biosynthesis polypeptide so that an aldol-dehydration product is produced, wherein:
the carbonyl group of the aliphatic aldehyde is not conjugated to a alkenyl, alkynyl, or aromatic group; and
the aldol-dehydration product is a compound comprising an aldehyde or ketone group and a double bond conjugated with the aldehyde or ketone group.

### Claim 2 (depends on 1)

The method of claim 1, wherein the aldol-dehydration product biosynthesis polypeptide is or comprises a hydratase-aldolase.

### Claim 3 (depends on 1)

The method of claim 1, wherein the aldol-dehydration product biosynthesis polypeptide is or comprises an enzyme having an EC number 4.1.2.45 or EC number 4.1.2.34, or EC 4.1.1.4, or is selected from Tables 1 and 5-8.

### Claim 4

(canceled)

### Claim 5

A method comprising:
contacting an alkene with an alkene reduction product biosynthesis polypeptide so that an alkene reduction product is produced, wherein:
the alkene reduction product biosynthesis polypeptide is or comprises an enzyme that belongs to EC 1.6.5 or is selected from Table 9;
the alkene comprises a double bond conjugated to a carbonyl group; and
a double bond conjugated to a carbonyl group in the alkene is reduced to a single bond to provide an alkene reduction product.

### Claim at position 6

6-7. (canceled)

### Claim 8 (depends on 2)

The method of claim 2, wherein the aliphatic aldehyde has the structure of formula A-1 thereof:
Ra-L2-L1-C(O)H, A-1
or a salt thereof, wherein:
Ra is R″ or —OR″,
each of L1 and L2 is independently a covalent bond, or a bivalent, optionally substituted, linear or branched C1-20 aliphatic or C1-20 heteroaliphatic, wherein one or more methylene units are optionally and independently replaced by —C≡C—, —C(R″)2—, -Cy-, —O—, —S—, —S—S—, —N(R″)—, —C(O)—, —C(S)—, —C(NR″)—, —C(O)N(R″)—, —N(R″)C(O)N(R″)—, —N(R″)C(O)O—, —S(O)—, —S(O)2—, —S(O)2N(R″)—, —C(O)S—, or —C(O)O—;
-Cy- is a bivalent, optionally substituted 3-20 membered monocyclic, bicyclic or polycyclic ring, wherein each monocyclic ring is independently an optionally substituted, saturated, partially saturated or aromatic 3-20 membered ring having 0-5 heteroatoms;
each R″ is independently —R′, —C(O)R′, —CO2R′, or —SO2R′;
R′ is hydrogen, or an optionally substituted group selected from C1-10 aliphatic, C1-10 heteroaliphatic having 1-5 heteroatoms, a 6-10 membered aryl ring, a 5-10 membered heteroaryl ring having 1-5 heteroatoms, and a 3-10 membered heterocyclic ring having 1-5 heteroatoms, or:
two or more R′ groups are taken together with their intervening atoms to form an optionally substituted 3-20 membered monocyclic, bicyclic or polycyclic ring having, in addition to the intervening atoms, 0-5 heteroatoms, wherein each monocyclic ring is independently an optionally substituted, saturated, partially saturated or aromatic 3-20 membered ring having 0-5 heteroatoms.

### Claim 9 (depends on 8)

The method of claim 8, wherein the aldol-dehydration product has the structure of formula P-2:
Ra-L2-L1-CH═CH—C(O)—C(O)OH, P-2
or a salt thereof, wherein:
Ra is R″ or —OR″,
each of L1 and L2 is independently a covalent bond, or a bivalent, optionally substituted, linear or branched C1-20 aliphatic or C1-20 heteroaliphatic, wherein one or more methylene units are optionally and independently replaced by —C≡C—, —C(R″)2—, -Cy-, —O—, —S—, —S—S—, —N(R″)—, —C(O)—, —C(S)—, —C(NR″)—, —C(O)N(R″)—, —N(R″)C(O)N(R″)—, —N(R″)C(O)O—, —S(O)—, —S(O)2—, —S(O)2N(R″)—, —C(O)S—, or —C(O)O—;
-Cy- is a bivalent, optionally substituted 3-20 membered monocyclic, bicyclic or polycyclic ring, wherein each monocyclic ring is independently an optionally substituted, saturated, partially saturated or aromatic 3-20 membered ring having 0-5 heteroatoms;
each R″ is independently —R′, —C(O)R′, —CO2R′, or —SO2R′;
R′ is hydrogen, or an optionally substituted group selected from C1-10 aliphatic, C1-10 heteroaliphatic having 1-5 heteroatoms, a 6-10 membered aryl ring, a 5-10 membered heteroaryl ring having 1-5 heteroatoms, and a 3-10 membered heterocyclic ring having 1-5 heteroatoms, or:
two or more R′ groups are taken together with their intervening atoms to form an optionally substituted 3-20 membered monocyclic, bicyclic or polycyclic ring having, in addition to the intervening atoms, 0-5 heteroatoms, wherein each monocyclic ring is independently an optionally substituted, saturated, partially saturated or aromatic 3-20 membered ring having 0-5 heteroatoms.

### Claim at position 9

10-11. (canceled)

### Claim 12 (depends on 9)

The method of claim 9, wherein the alkene reduction product has the structure of formula P-3:
Ra-L2-L1-CH2—CH2—C(O)—C(O)OH, P-3
or a salt thereof, wherein:
Ra is R″ or —OR″,
each of L1 and L2 is independently a covalent bond, or a bivalent, optionally substituted, linear or branched C1-20 aliphatic or C1-20 heteroaliphatic, wherein one or more methylene units are optionally and independently replaced by —C≡C—, —C(R″)2—, -Cy-, —O—, —S—, —S—S—, —N(R″)—, —C(O)—, —C(S)—, —C(NR″)—, —C(O)N(R″)—, —N(R″)C(O)N(R″)—, —N(R″)C(O)O—, —S(O)—, —S(O)2—, —S(O)2N(R″)—, —C(O)S—, or —C(O)O—;
-Cy- is a bivalent, optionally substituted 3-20 membered monocyclic, bicyclic or polycyclic ring, wherein each monocyclic ring is independently an optionally substituted, saturated, partially saturated or aromatic 3-20 membered ring having 0-5 heteroatoms;
each R″ is independently —R′, —C(O)R′, —CO2R′, or —SO2R′;
R′ is hydrogen, or an optionally substituted group selected from C1-10 aliphatic, C1-10 heteroaliphatic having 1-5 heteroatoms, a 6-10 membered aryl ring, a 5-10 membered heteroaryl ring having 1-5 heteroatoms, and a 3-10 membered heterocyclic ring having 1-5 heteroatoms, or:
two or more R′ groups are taken together with their intervening atoms to form an optionally substituted 3-20 membered monocyclic, bicyclic or polycyclic ring having, in addition to the intervening atoms, 0-5 heteroatoms, wherein each monocyclic ring is independently an optionally substituted, saturated, partially saturated or aromatic 3-20 membered ring having 0-5 heteroatoms.

### Claim at position 11

13-14. (canceled)

### Claim 15 (depends on 12)

The method of claim 12, wherein comprising converting a compound of formula P-3 or a salt thereof into a compound of formula P-4:
Ra-L2-L1-CH2—CH2—CH(OH)—C(O)OH, P-4
or a salt thereof, wherein:
Ra is R″ or —OR″,
each of L1 and L2 is independently a covalent bond, or a bivalent, optionally substituted, linear or branched C1-20 aliphatic or C1-20 heteroaliphatic, wherein one or more methylene units are optionally and independently replaced by —C≡C—, —C(R″)2—, -Cy-, —O—, —S—, —S—S—, —N(R″)—, —C(O)—, —C(S)—, —C(NR″)—, —C(O)N(R″)—, —N(R″)C(O)N(R″)—, —N(R″)C(O)O—, —S(O)—, —S(O)2—, —S(O)2N(R″)—, —C(O)S—, or —C(O)O—;
-Cy- is a bivalent, optionally substituted 3-20 membered monocyclic, bicyclic or polycyclic ring, wherein each monocyclic ring is independently an optionally substituted, saturated, partially saturated or aromatic 3-20 membered ring having 0-5 heteroatoms;
each R″ is independently —R′, —C(O)R′, —CO2R′, or —SO2R′;
R′ is hydrogen, or an optionally substituted group selected from C1-10 aliphatic, C1-10 heteroaliphatic having 1-5 heteroatoms, a 6-10 membered aryl ring, a 5-10 membered heteroaryl ring having 1-5 heteroatoms, and a 3-10 membered heterocyclic ring having 1-5 heteroatoms, or:
two or more R′ groups are taken together with their intervening atoms to form an optionally substituted 3-20 membered monocyclic, bicyclic or polycyclic ring having, in addition to the intervening atoms, 0-5 heteroatoms, wherein each monocyclic ring is independently an optionally substituted, saturated, partially saturated or aromatic 3-20 membered ring having 0-5 heteroatoms.

### Claim 16

(canceled)

### Claim 17 (depends on 15)

The method of claim 15, comprising converting a compound of formula P-4 or a salt thereof into a compound of formula P-5:
Ra-L2-L1-CH2—CH2—CH(OH)—C(O)—S—CoA, P-5
or a salt thereof.

### Claim 18

(canceled)

### Claim 19 (depends on 17)

The method of claim 17, comprising converting a compound of formula P-5 or a salt thereof into a compound of formula P-6:
Ra-L2-L1-CH2—CH═CH—C(O)—S—CoA, P-6
or a salt thereof.

### Claim 20

(canceled)

### Claim 21 (depends on 19)

The method of claim 19, comprising converting a compound of formula P-6 or a salt thereof into a compound of formula P-7:
Ra-L2-L1-CH2—CH2—CH2—C(O)—S—CoA, P-7
or a salt thereof.

### Claim 22

(canceled)

### Claim 23 (depends on 21)

The method of claim 21, comprising converting a compound of formula P-7 or a salt thereof into a compound of formula P-8:
Ra-L2-L1-CH2—CH2—CH2—C(O)—OH, P-8
or a salt thereof.

### Claim 24

(canceled)

### Claim 25 (depends on 23)

The method of claim 23, comprising converting a compound of formula P-8, wherein L2 is —CH2-L2′-, or a salt thereof into a compound of formula P-9:
H—C(O)-L2′-L1-CH2—CH2—CH2—C(O)—OH, P-9
or a salt thereof, and/or
converting a compound of formula P-9 or a salt thereof into a compound of formula P-10:
HO—C(O)-L2′-L1-CH2—CH2—CH2—C(O)—OH, P-10
or a salt thereof, wherein:
L2′ is a covalent bond, or a bivalent, optionally substituted, linear or branched C1-19 aliphatic or C1-19 heteroaliphatic, wherein one or more methylene units are optionally and independently replaced by —C≡C—, —C(R″)2—, -Cy-, —O—, —S—, —S—S—, —N(R″)—, —C(O)—, —C(S)—, —C(NR″)—, —C(O)N(R″)—, —N(R″)C(O)N(R″)—, —N(R″)C(O)O—, —S(O)—, —S(O)2—, —S(O)2N(R″)—, —C(O)S—, or —C(O)O—.

### Claim at position 23

26-28. (canceled)

### Claim 29 (depends on 23)

The method of claim 23, comprising converting a compound of formula P-8 or a salt thereof into a compound of formula P-9′:
Ra-L2-L1-CH2—CH2—CH2—C(O)—H, P-9′
or a salt thereof, and/or converting a compound of formula P-9′ or a salt thereof into a compound of formula P-10′:
Ra-L2-L1-CH2—CH2—CH2—CH2—OH, P-10′
or a salt thereof.

### Claim at position 25

30-32. (canceled)

### Claim 33 (depends on 12)

The method of claim 12, comprising converting a compound of formula P-3 or a salt thereof into a compound of formula P-4′:
Ra-L2-L1-CH2—CH2—C(O)—H, P-4′
or a salt thereof, and/or converting a compound of formula P-4′ or a salt thereof into a compound of formula P-5′:
Ra-L2-L1-CH2—CH2—CH2—OH, P-5′
or a salt thereof.

### Claim at position 27

34-65. (canceled)

### Claim 66 (depends on 1)

A preparation of a compound of formula P-1, P-2, P-3, P-4, P-4′, P-5, P-5′, P-6, P-7, P-8, P-9, P-9′, P-10, or P-10′, or a salt thereof, prepared by the method of claim 1, in which preparation is enriched for 14C isotope relative to that observed in a reference preparation of the compound, which reference preparation is prepared using fossil carbon source.

### Claim 67 (depends on 66)

A preparation of a polyester, a polyester polyol, a polyurethane, nylon 6, nylon 6,6, a polycarbonate diol, diacrylate ester, or diglycidyl ether, which preparation is manufactured using a preparation of claim 66.

### Claim 68

(canceled)

### Claim 69 (depends on 1)

An nucleic acid encoding the aldol-dehydration product biosynthesis polypeptides of claim 1, wherein the nucleic acid is optimized for expression in a microorganism.

### Claim 70

An engineered microbe that produces an aldol-dehydration product of an aliphatic aldehyde, the microbe comprising increased expression or activity of an aldol-dehydration product biosynthesis polypeptide, wherein:
the carbonyl group of the aliphatic aldehyde is not conjugated to a alkenyl, alkynyl, or aromatic group; and
the aldol-dehydration product is a compound comprising an aldehyde or ketone group and a double bond conjugated with the aldehyde or ketone group; or
an engineered microbe that produces an alkene reduction product, the microbe comprising increased expression or activity of an alkene reduction product biosynthesis polypeptide, wherein:
the alkene comprises a double bond conjugated to a carbonyl group; and
a double bond conjugated to a carbonyl group in the alkene is reduced to a single bond to provide an alkene reduction product.

### Claim 71

(canceled)

### Claim 72 (depends on 70)

A culture, comprising a microbe of claim 70, and one or more compounds independently of formulae P-1, P-2, P-3, P-4, P-5, P-6, P-7, P-8, P-9, P-10, P-9′, P-10′, P-4′ or P-5′, or a salt thereof.

### Claim 73

(canceled)
